Cargando…
Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC) accounts for ~75% of kidney cancers. The biallelic inactivation of the von Hippel–Lindau tumor suppressor gene (VHL) is the truncal driver mutation of most cases of ccRCC. Cancer cells are metabolically reprogrammed and excrete modified nucleosides in larger a...
Autores principales: | Mohl, Daniel A., Lagies, Simon, Zodel, Kyra, Zumkeller, Matthias, Peighambari, Asin, Ganner, Athina, Plattner, Dietmar A., Neumann-Haefelin, Elke, Adlesic, Mojca, Frew, Ian J., Kammerer, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136813/ https://www.ncbi.nlm.nih.gov/pubmed/37190010 http://dx.doi.org/10.3390/cells12081102 |
Ejemplares similares
-
Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma
por: Hoefflin, Rouven, et al.
Publicado: (2021) -
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
por: Seidel, Philipp, et al.
Publicado: (2022) -
SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC
por: Ganner, Athina, et al.
Publicado: (2023) -
Mitochondrial Metabolomics of Sym1-Depleted Yeast Cells Revealed Them to Be Lysine Auxotroph
por: Lagies, Simon, et al.
Publicado: (2023) -
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
por: Ganner, Athina, et al.
Publicado: (2021)